<--- Back to Details
First PageDocument Content
Stem cells / Brain tumor / Neuroblastoma / Chimeric antigen receptor / Immunotherapy / GD2 / Cell therapy / Cancer immunotherapy / Hematopoietic stem cell transplantation / Medicine / Biology / Immune system
Date: 2014-01-13 12:38:14
Stem cells
Brain tumor
Neuroblastoma
Chimeric antigen receptor
Immunotherapy
GD2
Cell therapy
Cancer immunotherapy
Hematopoietic stem cell transplantation
Medicine
Biology
Immune system

Basic Mechanisms of Oncology: Neuroblastoma

Add to Reading List

Source URL: osp.od.nih.gov

Download Document from Source Website

File Size: 1,12 MB

Share Document on Facebook

Similar Documents

# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,*,#, Stephen M. Shaw 1,*, Kim Wi

DocID: 1vdls - View Document

Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx

DocID: 1uTyz - View Document

FALL/WINTERUCSF Oncology Connection Oncologist Lawrence Fong, MD, is leading UCSF’s newly launched Cancer Immunotherapy Program

DocID: 1tGAn - View Document

Cancer Immunotherapy & Personalized Vaccines Alex Rubinsteyn Mount Sinai, Hammer Lab

DocID: 1tBVB - View Document